Basics Liquidia Technologies, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Biotech Market Cap: $2.48B Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 3.40% Avg Daily Range (30 D): $0.70 | 3.10% Avg Daily Range (90 D): $0.54 | 3.06% Institutional Daily Volume Avg Daily Volume: .65M Avg Daily Volume (30 D): 2.67M Avg Daily Volume (90 D): 2.3M Trade Size Avg Trade Size (Sh.): 104 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 736 Avg Inst. Trade: $1.69M Avg Inst. Trade (30 D): $2.56M Avg Inst. Trade (90 D): $2.35M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.96M Avg Closing Trade (30 D): $5.03M Avg Closing Trade (90 D): $3.61M Avg Closing Volume: 158.87K     News Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight May 23, 2025 @ 6:28 PM U.S. FDA Approves Liquidia’s YUTREPIAâ„Â... Source: Liquidia Corporation May 12, 2025 @ 10:00 AM Liquidia Corporation Provides Update on Litigation... Source: N/A May 2, 2025 @ 9:28 PM District Court Dismisses Dispute Filed by United T... Source: Liquidia Corporation Mar 12, 2025 @ 12:00 PM Liquidia Corporation to Report Full Year 2024 Fina... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.7 $-.49 $-.45 Diluted EPS $-1.7 $-.49 $-.45 Revenue $ 19.32M $ 8.84M $ 3.12M Gross Profit $ $ $ 1.6M Net Income / Loss $ -141.47M $ -41.58M $ -38.37M Operating Income / Loss $ -138.23M $ -37.51M $ -35.43M Cost of Revenue $ $ $ 1.52M Net Cash Flow $ 43.83M $ 7.17M $ -6.72M PE Ratio